Gary Jerkins

535 total citations
11 papers, 102 citations indexed

About

Gary Jerkins is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gary Jerkins has authored 11 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Ophthalmology, 8 papers in Public Health, Environmental and Occupational Health and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gary Jerkins's work include Ocular Surface and Contact Lens (8 papers), Glaucoma and retinal disorders (6 papers) and Olfactory and Sensory Function Studies (3 papers). Gary Jerkins is often cited by papers focused on Ocular Surface and Contact Lens (8 papers), Glaucoma and retinal disorders (6 papers) and Olfactory and Sensory Function Studies (3 papers). Gary Jerkins collaborates with scholars based in United States, Australia and Japan. Gary Jerkins's co-authors include Guruprasad R. Pattar, Jacqueline Tan, Laura E. Downie, Penny A. Asbell, Algis J. Vingrys, Abayomi Ogundele, Gail Torkildsen, Joseph Tauber, Almira Chabi and Jack V. Greiner and has published in prestigious journals such as SHILAP Revista de lepidopterología, Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Gary Jerkins

9 papers receiving 96 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Jerkins United States 7 81 49 39 27 23 11 102
Robert Smyth-Medina United States 7 92 1.1× 51 1.0× 45 1.2× 44 1.6× 30 1.3× 11 149
Yuandong Su China 4 56 0.7× 32 0.7× 35 0.9× 4 0.1× 15 0.7× 4 69
R. Q. Spain 2 57 0.7× 25 0.5× 18 0.5× 5 0.2× 19 0.8× 2 59
Gerald B. Walman United States 3 23 0.3× 38 0.8× 19 0.5× 6 0.2× 10 0.4× 6 60
Joseph Gira United States 2 56 0.7× 70 1.4× 21 0.5× 11 0.4× 4 0.2× 3 84
V.V. Brzheskiy Russia 6 42 0.5× 59 1.2× 35 0.9× 4 0.2× 40 80
Purvi Bhagat India 6 36 0.4× 73 1.5× 41 1.1× 3 0.1× 1 0.0× 25 97
Louis Alpern United States 3 19 0.2× 66 1.3× 17 0.4× 3 0.1× 2 0.1× 3 73
Yury S. Astakhov Russia 6 46 0.6× 103 2.1× 45 1.2× 3 0.1× 23 111

Countries citing papers authored by Gary Jerkins

Since Specialization
Citations

This map shows the geographic impact of Gary Jerkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Jerkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Jerkins more than expected).

Fields of papers citing papers by Gary Jerkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Jerkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Jerkins. The network helps show where Gary Jerkins may publish in the future.

Co-authorship network of co-authors of Gary Jerkins

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Jerkins. A scholar is included among the top collaborators of Gary Jerkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Jerkins. Gary Jerkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Pattar, Guruprasad R., David Wirta, Gary Jerkins, et al.. (2025). Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease. Ophthalmology.
3.
Olander, Kenneth W., Gary Jerkins, Fenghe Lu, et al.. (2021). A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6). Journal of Glaucoma. 30(6). 473–480. 13 indexed citations
4.
Jerkins, Gary, Jack V. Greiner, Louis Tong, et al.. (2020). A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease. SHILAP Revista de lepidopterología.
5.
Olander, Kenneth W., Gary Jerkins, Fenghe Lu, et al.. (2020). A randomized Phase 2 trial assessing the safety and efficacy of omidenepag isopropyl 0.002% once and twice daily in subjects with primary open-angle glaucoma or ocular hypertension (Spectrum 6). Investigative Ophthalmology & Visual Science. 61(7). 4258–4258. 1 indexed citations
6.
Jerkins, Gary, et al.. (2020). <p>A Review of Topical Cyclosporine A Formulations—A Disease-Modifying Agent for Keratoconjunctivitis Sicca</p>. Clinical ophthalmology. Volume 14. 481–489. 22 indexed citations
7.
Jerkins, Gary, Jack V. Greiner, Louis Tong, et al.. (2020). <p>A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease</p>. Clinical ophthalmology. Volume 14. 1665–1673. 15 indexed citations
8.
Pattar, Guruprasad R., Gary Jerkins, David G. Evans, et al.. (2019). Symptom improvement in dry eye subjects following intranasal tear neurostimulation: Results of two studies utilizing a controlled adverse environment. The Ocular Surface. 18(2). 249–257. 12 indexed citations
9.
Senchyna, Michelle, George W Ousler, Gary Jerkins, et al.. (2018). Effect of TrueTear™ on Dry Eye Symptoms During Exposure to a Controlled Adverse Environment. 59(9). 918–918. 2 indexed citations
10.
Asbell, Penny A., Algis J. Vingrys, Jacqueline Tan, et al.. (2018). Clinical Outcomes of Fixed Versus As-Needed Use of Artificial Tears in Dry Eye Disease: A 6-Week, Observer-Masked Phase 4 Clinical Trial. Investigative Ophthalmology & Visual Science. 59(6). 2275–2275. 18 indexed citations
11.
Jerkins, Gary, et al.. (1983). Comparison of atropine and tropicamide in esotropia.. PubMed. 15(4). 341–3. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026